全球对运动障碍性疾病的临床神经生理学的认知和应用。
Global Perceptions and Utilization of Clinical Neurophysiology in Movement Disorders.
机构信息
Department of Neurology, University of Utah, Salt Lake City, UT, USA.
Krembil Research Institute, University of Toronto, Toronto, ON, Canada.
出版信息
Mov Disord Clin Pract. 2024 Apr;11(4):346-351. doi: 10.1002/mdc3.13974. Epub 2024 Feb 11.
BACKGROUND
Clinical neurophysiology (CNP) involves the use of neurophysiological techniques to make an accurate clinical diagnosis, to quantify the severity, and to measure the treatment response. Despite several studies showing CNP to be a useful diagnostic tool in Movement Disorders (MD), its more widespread utilization in clinical practice has been limited.
OBJECTIVES
To better understand the current availability, global perceptions, and challenges for implementation of diagnostic CNP in the clinical practice of MD.
METHODS
The International Parkinson and Movement Disorders Society (IPMDS) formed a Task Force on CNP. The Task Force distributed an online survey via email to all the members of the IPMDS between August 5 and 30, 2021. Descriptive statistics were used for analysis of the survey results. Some results are presented by IPMDS geographical sections namely PanAmerican (PAS), European (ES), African (AFR), Asian and Oceanian (AOS).
RESULTS
Four hundred and ninety-one IPMDS members (52% males), from 196 countries, responded. The majority of responders from the AFR (65%) and PAS (63%) sections had no formal training in diagnostic CNP (40% for AOS and 37% for ES). The most commonly used techniques are electroencephalography (EEG) (72%) followed by surface EMG (71%). The majority of responders think that CNP is somewhat valuable or very valuable in the assessment of MD. All the sections identified "lack of training" as one of the biggest challenges for diagnostic CNP studies in MD.
CONCLUSIONS
CNP is perceived to be a useful diagnostic tool in MD. Several challenges were identified that prevent widespread utilization of CNP in MD.
背景
临床神经生理学（CNP）涉及使用神经生理学技术进行准确的临床诊断、量化严重程度和测量治疗反应。尽管有几项研究表明 CNP 是运动障碍（MD）的有用诊断工具，但在临床实践中更广泛地应用受到限制。
目的
更好地了解当前在 MD 的临床实践中进行诊断性 CNP 的可用性、全球认知和实施挑战。
方法
国际帕金森病和运动障碍学会（IPMDS）成立了一个 CNP 工作组。该工作组于 2021 年 8 月 5 日至 30 日通过电子邮件向所有 IPMDS 成员分发了在线调查。使用描述性统计对调查结果进行分析。一些结果按 IPMDS 地理区域呈现，即泛美（PAS）、欧洲（ES）、非洲（AFR）、亚洲和大洋洲（AOS）。
结果
来自 196 个国家的 491 名 IPMDS 成员（52%为男性）做出了回应。来自 AFR（65%）和 PAS（63%）部分的大多数应答者没有接受过诊断性 CNP 的正规培训（AOS 为 40%，ES 为 37%）。最常用的技术是脑电图（EEG）（72%），其次是表面肌电图（71%）。大多数应答者认为 CNP 在 MD 的评估中具有一定价值或非常有价值。所有部分都认为“缺乏培训”是 MD 中诊断性 CNP 研究的最大挑战之一。
结论
CNP 被认为是 MD 的有用诊断工具。确定了一些挑战，这些挑战阻止了 CNP 在 MD 中的广泛应用。
Zotero 插件